MedTrace Logo

Use of Methoxyflurane (Penthrox) as an Antalgic in Hospital Trauma

NCT03927729 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2021-05-06

No results posted yet for this study

Summary

Study of traumatized patients treated in emergency departments of Tours, seeking to optimize the management of trauma pain in an inpatient setting, with the opportunity to integrate inhaled methoxyflurane (Penthrox®) into the arsenal analgesics useful in the analgesic protocol of the Reception and Orientation Nurse.

Conditions

  • Pain
  • Traumatic Injury

Interventions

DRUG

Methoxyflurane

Pain will be treated with inhaled methoxyflurane (Penthrox®).

Sponsors & Collaborators

  • University Hospital, Tours

    lead OTHER

Principal Investigators

  • Julien CONRAS, MD · University Hospital, Tours

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-07
Primary Completion
2020-03-11
Completion
2020-03-11

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03927729 on ClinicalTrials.gov